Coronaviruses are able to cause massive disease outbreaks. These infectious viruses can trigger severe respiratory diseases which sometimes even lead to death. A new real-time RT-PCR test helps to [...]
What would you say is the world’s most dangerous animal? A wolf? A shark? Wrong – it’s the mosquito. Mosquitoes transmit diseases causing over a million deaths every year. For World Mosquito Day, [...]
Zoonoses are infectious diseases which can be transmitted from animals to humans. More than 200 of these diseases are known. On World Zoonoses Day on July 6 we are presenting the most common [...]
Can you tolerate these foods? More and more people can’t due to food allergies. On the occasion of Food Allergy Day, we reported last week on type I allergies. Today, we will devote our [...]
Not all allergies are alike. At the food allergy awareness day on June 21st, we will be dealing with food allergies in children and will show what is actually important for a diagnosis.
The drug adalimumab is used very successfully in the treatment of various inflammatory diseases. Yet in some patients, the efficacy of this drug decreases over time. We explain why this is so and how [...]
May is completely characterized by intestinal health: first Digestive Disease Week, now World IBD Day. The aim of the IBD action day is to raise awareness about inflammatory bowel diseases (IBDs). [...]
Therapeutic drug monitoring (TDM) is used to measure the concentration of an active ingredient in the patient’s blood. Using this information, physicians can adjust the dose individually to the [...]
April 25 is World Malaria Day: A good opportunity to take a look at the current prophylaxis, diagnosis, and treatment of this dangerous tropical disease that claims around 400,000 lives each year.
Tick season has started and the risk of dangerous infections with TBE/FSME is increasing. In the event of a suspected infection and to clarify immunization, antibody detection is the method of choice.
As every year, March is officially “Colon Cancer Awareness Month”. A great opportunity to highlight the importance of screening. Nowadays, modern tests have made the early detection of colon [...]
So-called TNFα blockers are commonly used in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Therapeutic drug monitoring improves the effect of the [...]
RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human tissue [...]
R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the [...]
Excellent results of the RIDA®GENE MRSA real-time PCR assay in the external quality assessment program of Instand e.V. Repeatedly, the R-Biopharm AG participated successfully in the INSTAND external [...]
The RIDA®GENE real-time PCR assays (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) successfully detected the suggested vaccination strains for influenca of the 2015/2016 season.
Chronic inflammatory bowel disease (IBD) is characterized by recurring and often ongoing flares. The most common forms of IBD are Crohns disease and Ulcerative colitis.
It is often difficult to differentiate patients with inflammatory bowel disease (IBD) those who suffer from irritable bowel syndrome due to similar symptoms of patients. Both groups show similar [...]
According to the Robert Koch Institute (RKI) every year 63.000 people in Germany fall ill with colon cancer. Approximately 25,000 people die annually from the consequences of this disease. Colon [...]
TNFalpha blocker are biologic agents, which are used for the treatment of inflammatory diseases such as Ulcerative Colitis, Crohns disease and Rheumatoid Arthritis. Infliximab (Remicade®, RemsimaTM, [...]
Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn.
Study about first randomized, controlled testing shows that clinical treatment decisions based on therapeutic drug monitoring (TDM) is superior to dose-intensification strategy. One common way of [...]
The RIDA®GENE real-time PCR assays for the detection of Influenza (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) detect the currently circulating drift variant of influenza A (H3N2).
Ann Gils and her colleagues from KU Leuven evaluated if the biosimilars RemsimaTM and Inflectra® were equally well quantified as Remicade® (Infliximab, IFX) in their clinically validated infliximab assay.
Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical and [...]
RIDASCREEN® IFX Monitoring is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, Remicade®, anti-TNFα) in human serum and plasma. It is the commercialized [...]
Sustainable excellence in longterm and profitable growth awarded After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row this [...]
RIDA®GENE Enterovirus PCR test – New real-time RT-PCR Assay for the detection of the major human enteroviruses Human enteroviruses comprise a variety of different pathogens: poliovirus, [...]
The product change results in a standardization of the serological diagnosis of parasites to the product line RIDASCREEN® Sero ELISA.
RIDA®GENE Gastro Panel – “Multiplex” your way to individualised patient management Due to increasing demands for routine laboratories to speed up diagnosis and provide reliable diagnosis of the [...]
Quantitative, fast and reliable analysis with Pancreatic Elastase ELISA from BIOSERV About 50 % of Type-1-Diabetics, 33 % Type-2-Diabetics and 75 – 80 % Mucoviscidosis patients develop [...]
The Next Generation of Allergy In-Vitro-Diagnostics R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a [...]
With its latest rapid test, R-Biopharm is now able to offer a complete solution for the immunological diagnosis of Clostridium difficile in compliance with the new international guidelines of various [...]
Progress in reliability at simplified work flow The RIDA®QUICK Norovirus Test is a qualitative immunochromatographic lateral flow rapid test for determining Genogroup 1 (GG I) and Genogroup 2 (GG II) [...]
From now on R-Biopharm expands its portfolio in the Gastroenterology product group The Pancreatic Elastase ELISA (G09038) for the quantitative determination of pancreatic elastase in feces enables to [...]
RIDA®QUICK Rotavirus /Adenovirus Sample Diluent Kit is supplied as an accessory for sampling and diluting stool samples in connection use the corresponding RIDA®QUICK rapid tests for the detection of [...]
Reliable MRSA Screening for Hospitals and Laboratories in less than 2 hours. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most dreaded causes of nosocomial infections in hospitals [...]
New line blot immunoassays – Reliable differentiation between human IgG and IgA antibodies against Helicobacter pylori type I and II strains. More than half of the world population is infected with [...]
RIDA®GENE ETEC/EIEC multiplex real-time PCR completes the RIDA®GENE product portfolio for the detection of pathogenic E. coli
RIDA®GENE ETEC/EIEC enables a specific and direct detection of the major pathogens of traveller’s diarrhea: ETEC/EIEC and Shigella spp. in less than 2 hours. Enterotoxigenic E.coli (ETEC) are the [...]
R-Biopharm AG has developed a one-step rapid test based on lateral flow technology. This simple test enables direct detection of C. difficile toxins A and B in well homogenized stool samples in only [...]
R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC rapid [...]
RIDA®GENE EHEC/EPEC multiplex real-time PCR: Specific and direct detection of the lethal EHEC bacteria in less than 2 hours
Currently an increased number of diseases and suspected cases are linked to the intestinal pathogen EHEC (enterohämorrhagic E. coli). Noticeable are the numbers of severe diseases with complications [...]
The Danish company REFLAB became a member of the R-Biopharm group on January 1, 2010. As a supplier of test kits for the detection of autoreactive urticaria and histamine release tests for the [...]
New and improved versions of the RIDASCREEN®Rotavirus and RIDASCREEN®Adenovirus tests by R-Biopharm AG are available starting immediately.
Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people [...]